Table 1 Demographic characteristics of the respondents
Characteristics | Number of respondents, n (%) N = 1027 |
|---|---|
Age in years | |
22–29 | 126 (12.3) |
30–39 | 359 (35.0) |
40–49 | 355 (34.6) |
50–59 | 137 (13.3) |
≥ 60 | 50 (4.9) |
Marital status | |
Married/cohabiting | 1015 (98.8) |
Single | 12 (1.2) |
Parity | |
Parous | 859 (83.6) |
Nulliparous | 168 (16.4) |
Grade of hospital | |
1 | 60 (5.8) |
2 | 431 (42.0) |
3 | 536 (52.2) |
Specialty | |
Gynecological endocrinology | 77 (7.5) |
Gynecology | 465 (45.3) |
Obstetrics | 79 (7.7) |
Obstetrics and gynecology | 406 (39.5) |
History of clinical confirmed diseases | |
Hyperlipidemia | 66 (6.4) |
Cardiovascular diseases | 36 (3.5) |
Diabetes mellitus | 16 (1.6) |
Low bone density/osteoporosis | 29 (2.8) |
Hyperthyroidism/hypothyroidism | 5 (0.6) |
Menstrual status | |
Amenorrhea (menopause and total hysterectomy) | 197 (19.1) |
Oligomenorrhea | 72 (7) |
Moderate menstrual flow | 648 (63.1) |
Menorrhagia | 110 (10.6) |
Reasons for induced abortions | |
Unreliable contraceptive method | 317 (55.5) |
Failure of reliable contraceptive method | 108 (18.9) |
Unintended pregnancy in spite of reliable contraceptive method | 64 (11.2) |
Use of emergency contraception | 24 (4.2) |
Disease | 5 (0.9) |
Medications used during pregnancy | 7 (1.2) |
Suspending embryo growth | 3 (0.5) |
Abnormal development of fetus | 3 (0.5) |